Clinical Trials
226 trialsDESCENT-1
A2 Biotherapeutics Inc.
3D Specimen Maps for RT Planning
Vanderbilt University Medical Center
DEMO
Hospices Civils de Lyon
HNC-TACTIC
Savana Research
ELEPHAS-02
Elephas
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
UNC Lineberger Comprehensive Cancer Center
Oropharynx (OPX) Biomarker Trial
Mayo Clinic
POLARIS
University Hospital, Brest
A Bidirectional Study of Individualized Postoperative Adjuvant Treatment Decision Model for Locally Advanced Head and Neck Squamous Cell Carcinoma Based on Multimodal Dynamic Data
Nanfang Hospital, Southern Medical University
AID-OraL
Assistance Publique - Hôpitaux de Paris
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Tempus AI
GALENOS 1
Fondazione del Piemonte per l'Oncologia
BIOMATCH
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
The Role of Circulating Tumour DNA in Head and Neck Cancer
University of Edinburgh
SPAR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
DoIT_Neck
University of Erlangen-Nürnberg Medical School
CTCO
Hospices Civils de Lyon
PEMBRO-PET
University of Rome Tor Vergata
PREDAPT-HNSCC2
Cofactor Genomics, Inc.
MicroRNA Markers in Head and Neck Cancers
University of Colorado, Denver
Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip
National Taiwan University Hospital
MOSES
Royal Marsden NHS Foundation Trust
HN-ORAL-RT
Ain Shams University
The Registry Study of Genetic Alterations of Oropharyngeal Cancer in Taiwan
National Health Research Institutes, Taiwan
DECT-CEco
University Hospital, Strasbourg, France
Collagen Matrix in Oral Cancer Surgery
Hôpital de la Croix-Rousse
MASST
University Health Network, Toronto
Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck Region
Maastricht University Medical Center
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
Pharmassist Ltd
Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma
University of California, San Francisco
Clear-HPVca
Massachusetts Eye and Ear Infirmary
NEUTROFLOW
OncoHost Ltd.
Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples?
Rigshospitalet, Denmark
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Vanderbilt University Medical Center
The Head and Neck Tumor Biobank
Maastricht Radiation Oncology
ST-ICI02
University of Erlangen-Nürnberg Medical School
Real-world Study of First Line Pembrolizumab- or Nivolumab-treated HPV-positive Recurrent/Metastatic Oropharyngeal Squamous Cell Carcinoma
Hookipa Biotech GmbH
PDO Based Drug Sensitive Test in R/M HNSCC
Huashan Hospital
ORACLE
Guardant Health, Inc.
A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC
Zhujiang Hospital
Immune Response in Cervical Lymph Nodes of Patients With Head and Neck Cancer
Karolinska Institutet
Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell Carcinoma
Al-Azhar University
Saliva Testing for High-Risk Human Papillomavirus Infection Oral Cavity and Pharynx Cancer
Wake Forest University Health Sciences
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
National Cancer Institute, Naples
Post-treatment Surveillance in HPV+ Oropharyngeal SCC
Dana-Farber Cancer Institute
Case Review of Patients With Betel Nut-induced Oral Cancer Treated With Pembrolizumab and Cetuximab
Commonwealth Healthcare Corporation
People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity
University of California, San Francisco
Radiomics Model for Assessing Lymph Node Status in cN0 Patients withHNSCC
First Affiliated Hospital of Chongqing Medical University
SYMILIS OCT
University of Palermo
Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC
New Mexico Cancer Research Alliance